Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This will be a randomized, double-blind, placebo-controlled study. The study will use a three-period, six-sequence, complete-block, cross-over study design to characterize two doses of inhaled TD-8236 compared to placebo in subjects with mild asthma and a known response to an allergen. Each of the three periods will be 14 days, followed by a washout period before the next period.
Epistemonikos ID: 53e734dd389bf39b90daefbf43127585b8363c63
First added on: May 06, 2024